Michael Rosenblatt Merck & Co., Inc. (MRK) insider trading activity

Michael Rosenblatt is Exec V-P & Chief Med Officer of Merck & Co., Inc.. Currently has a direct ownership of 41,133 shares of MRK, which is worth approximately $4.85 Million. The most recent transaction as insider was on Feb 22, 2016, when has been sold 7,738 shares (Common Stock) at a price of $50.77 per share, resulting in proceeds of $392,858. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.1K

0% 3M change

0% 12M change

Total Value Held $4.85 Million

Michael Rosenblatt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2016	BUY Grant, award, or other acquisition	$392,858 $50.77 p/Share	7,738 Added 15.83%	41,133 Common Stock
May 02 2015	SELL Payment of exercise price or tax liability	$118,523 $59.86 p/Share	1,980 Reduced 5.73%	32,553 Common Stock
May 02 2015	BUY Exercise of conversion of derivative security	-	3,818 Added 9.96%	34,533 Common Stock
Feb 23 2015	BUY Grant, award, or other acquisition	$291,558 $58.3 p/Share	5,001 Added 14.1%	30,477 Common Stock
May 04 2014	SELL Payment of exercise price or tax liability	$104,738 $58.22 p/Share	1,799 Reduced 6.73%	24,920 Common Stock
May 04 2014	BUY Exercise of conversion of derivative security	-	4,103 Added 13.31%	26,719 Common Stock

Also insider at

AZTA

Azenta, Inc. Healthcare

RUBY

Rubius Therapeutics, Inc. Healthcare

Director

AXLA

Axcella Health Inc. Healthcare

Director